Clinical Trial Update: The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating toripalimab (JS001) in advanced gastric cancer and multiple squamous cell carcinomas including esophageal, nasopharyngeal, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Gastric Adenocarcinoma
• Head and Neck Squamous Cell Carcinoma
• Nasopharyngeal Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Gastric Adenocarcinoma, Esophageal Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN